Immune Infiltration Profiling in Nonsmall Cell Lung Cancer and Their Clinical Significance: Study Based on Gene Expression Measurements
- PMID: 31549881
- DOI: 10.1089/dna.2019.4899
Immune Infiltration Profiling in Nonsmall Cell Lung Cancer and Their Clinical Significance: Study Based on Gene Expression Measurements
Abstract
Immune cell infiltration is associated with the prognosis of cancer. This study focused on the immune infiltration profiling and their association with survival outcome in nonsmall cell lung cancer (NSCLC). Research data were obtained from the Gene Expression Omnibus and The Cancer Genome Atlas databases. CIBERSORT algorithm was applied to assess the relative proportions of 22 kinds of immune cells. Log-rank test was performed to compare the survival outcome of patients with different proportions of immune cells. The estimated hazard ratios were presented with forest plot. Multivariate Cox regression analysis was conducted to estimate the adjusted associations between different types of infiltrating immune cells and survival prognosis controlling for other clinical features and confounders. With the CIBERSORT approach, we assessed the proportions of 22 infiltrating immune cells of 2050 cases with NSCLC. By conducting survival analysis, we found different survival outcomes among cases with different proportions of certain types of infiltrating immune cells. Among the cell subsets investigated, plasma cells (hazard ratio [HR] = 0.775, 95% confidence interval [CI]: 0.669-0.898) and regulatory T cells (HR = 1.258, 95% CI: 1.091-1.451) were associated with survival outcome of NSCLC patients controlling for other covariates. Subgroup analysis suggested a good consistency and robustness of our results. Our findings might provide useful information for prognosis prediction and cellular study in NSCLC.
Keywords: gene signature; immune infiltration; nonsmall cell lung cancer; survival.
Similar articles
-
Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.Biomed Res Int. 2021 Mar 30;2021:8864436. doi: 10.1155/2021/8864436. eCollection 2021. Biomed Res Int. 2021. PMID: 33860055 Free PMC article.
-
APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC.BMC Cancer. 2021 Mar 6;21(1):233. doi: 10.1186/s12885-021-07950-1. BMC Cancer. 2021. PMID: 33676448 Free PMC article.
-
Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.Int Immunopharmacol. 2020 Sep;86:106744. doi: 10.1016/j.intimp.2020.106744. Epub 2020 Jul 2. Int Immunopharmacol. 2020. PMID: 32623229
-
Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis.Oncotarget. 2016 Jun 14;7(24):36065-36073. doi: 10.18632/oncotarget.9130. Oncotarget. 2016. PMID: 27153545 Free PMC article. Review.
-
The expression profile and clinic significance of the SIX family in non-small cell lung cancer.J Hematol Oncol. 2016 Nov 8;9(1):119. doi: 10.1186/s13045-016-0339-1. J Hematol Oncol. 2016. PMID: 27821176 Free PMC article. Review.
Cited by
-
Recurrence prediction of lung adenocarcinoma using an immune gene expression and clinical data trained and validated support vector machine classifier.Transl Lung Cancer Res. 2023 Oct 31;12(10):2055-2067. doi: 10.21037/tlcr-23-473. Epub 2023 Oct 27. Transl Lung Cancer Res. 2023. PMID: 38025809 Free PMC article.
-
Exploration of prognostic biomarkers in head and neck squamous cell carcinoma microenvironment from TCGA database.Ann Transl Med. 2023 Feb 28;11(4):163. doi: 10.21037/atm-22-6481. Ann Transl Med. 2023. PMID: 36923087 Free PMC article.
-
Systematic analysis of expression profiles of HMGB family members for prognostic application in non-small cell lung cancer.Front Mol Biosci. 2022 Jul 18;9:844618. doi: 10.3389/fmolb.2022.844618. eCollection 2022. Front Mol Biosci. 2022. PMID: 35923467 Free PMC article.
-
An immunosuppressive scoring system to predict recurrence and assist in decision regarding postoperative adjuvant treatment in gastric cancer.Am J Cancer Res. 2022 May 15;12(5):2050-2067. eCollection 2022. Am J Cancer Res. 2022. PMID: 35693074 Free PMC article.
-
KRT8 Serves as a Novel Biomarker for LUAD and Promotes Metastasis and EMT via NF-κB Signaling.Front Oncol. 2022 May 19;12:875146. doi: 10.3389/fonc.2022.875146. eCollection 2022. Front Oncol. 2022. PMID: 35664775 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
